Rabbit Polyclonal ABIN3 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human TNIP3 conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
ABIN3, LIND, TNIP3, TNFAIP3-interacting protein 3, A20-binding inhibitor of NF-kappa-B activation 3, Listeria-induced gene protein, ABIN-3
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ABIN3 antibody (AB113748)
ab113748, at 5 µg/ml, staining ABIN3 in formalin fixed, paraffin embedded, Human adrenal tissue by Immunohistochemistry
- WB
Unknown
Western blot - Anti-ABIN3 antibody (AB113748)
All lanes:
Western blot - Anti-ABIN3 antibody (ab113748) at 1 µg/mL
Lane 1:
Human spleen tissue lysate
Lane 2:
Human spleen tissue lysate with blocking peptide
Predicted band size: 39 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ABIN3 regulates immune response and participates in controlling inflammation. It acts together with other components to form signaling complexes. This complex assembly plays a role in dampening excessive inflammatory signals. By regulating components of innate immune responses ABIN3 helps maintain immune homeostasis. Its interaction is significant in controlling the overall activity within signaling hubs that manage inflammation.
Pathways
ABIN3 involves itself in critical inflammatory pathways such as the NF-κB pathway. This protein modulates NF-κB activation by hindering its activity ensuring proper balance in immune signaling. ABIN3 connects with proteins like A20 acting together to prevent overactivation that could lead to inflammation. Such modulation is central in managing cellular defenses and preventing inappropriate tissue damage.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cancer cell international 23:49 PubMed36932402
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:5210870 PubMed35368864
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 31:726-740.e8 PubMed32268115
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com